Home » Topics » Regulatory

Regulatory
RSS

Advisory committee recommends Taxol for KS

June 27, 1997

RTP Pharma receives U.S. patent for new formulation of propofol

June 25, 1997

Minocycline superior to placebo for early RA

June 25, 1997

Pulmicort Turbuhaler approved by FDA

June 25, 1997

Combination therapy approved by FDA for H. pylori eradication

June 20, 1997

Coreg now available in the U.S. for heart failure

June 18, 1997

DuPont Merck's breast imaging agent approved in the U.K.

June 18, 1997

RPR seeks approval for enoxaparin for unstable angina in Europe

June 18, 1997

New vial size of generic leucovorin approved by FDA

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Elixirgen and Nippon Shinyaku sign EXG-7001 option agreement
BioWorld Science
Elixirgen Therapeutics Inc. has entered into an option agreement with Nippon Shinyaku Co. Ltd. for the development and commercialization of EXG-7001 for Duchenne...
Investors bet on transformative BCI tech for neuro disorders
BioWorld
An estimated $2 billion has been invested in the brain-computer interface (BCI) space in the last two years and the level of funding is expected to continue....
Shanghai Yingli Pharmaceutical identifies new KRAS mutant inhibitors
BioWorld Science
Shanghai Yingli Pharmaceutical Co. Ltd. has discovered hydrazine-structured compounds as inhibitors of GTPase KRAS and its mutants. They are reported to be useful...